Anixa Biosciences (NASDAQ: ANIX)
$3.12
(-3.4%)
-$0.11
Price as of March 28, 2024, 4:00 p.m. ET
Anixa Biosciences Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Anixa Biosciences Company Info
Anixa Biosciences, Inc. is a biotechnology company, which engages in developing therapies and vaccines that are focused on critical unmet needs in oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, Cancer Diagnostics, and Patent Licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
News & Analysis
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.